CVS Health Corporation (1CVS)
MTA
79.50
-0.46 (-0.58%)
Closed
Aug 24, 2026
Day's Range
79.4079.50
52 wk Range
60.1595.80
Financial Statements - 1CVS - CVS Health Corporation
Revenue
402.06B▲ 28.3%
Net Income
1.72B▼ 55.2%Net Margin 0.4%
EBITDA
15.10B▲ 24.0%
Free Cash Flow
7.80B▲ 46.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 402.06B | 313.28B |
| Cost of Goods | 346.70B | 270.08B |
| Gross Profit | 55.36B | 43.19B |
 Operating Expense | - | - |
| Operating Income | 10.38B | 8.23B |
| Non-Operating Interest | - | - |
| Other Income Expense | -5.13B | -578.98M |
| Pre Tax Income | 2.13B | 5.16B |
| Income Tax | 408M | 1.31B |
| Net Income | 1.72B | 3.85B |
| EPS Basic | 1.4 | 3.67 |
| EPS Diluted | 1.39 | 3.66 |
| Basic Shares Outstanding | 1.26B | 1.05B |
| Diluted Shares Outstanding | 1.26B | 1.05B |
| Ebit | 5.25B | 7.65B |
| Ebitda | 15.10B | 12.17B |
| Net Income Continuous Operations | 1.72B | 3.85B |
| Minority Interests | 40M | 28M |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
